Patricia Andrews

Track

Insider profile

Currently holds a position at Crescent Biopharma Inc

Performance

Overall performance
0.5
Performance over holding periods
0.5
30 days 90 days 120 days
Average return -24% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director Crescent Biopharma Inc June 12, 2017 -
Executive Vice President, Chief Commercial Officer Incyte Corp Oct. 20, 2008 - Aug. 29, 2012
Patricia Andrews's trades of Oncolytics Biotech Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-13 2026-02-12
B Purchase
69,815 +4.3%
201.95
US$818,925 		69,815 +4.3% 201.95 US$818,925
2021-11-18 2021-11-16
B Purchase
11,529 +8.7%
87.80
US$2,466,659 		11,529 +8.7% 87.80 US$2,466,659